About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Lymphoma Clinical Trials | 6,591 Studies Recruiting

Clinical TrialsLymphoma

Lymphoma Clinical Trials

Browse 6,591 clinical trials for lymphoma. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 5781-5800 of 6,591 trials

CompletedCyclophosphamide W/or W/Out Rituximab and Peripheral Stem Cell Transplantation in Patients With Recurrent Non-Hodgkin's LymphomaRATIONALE: Monoclonal antibodies such as rituximab can locate cancer cells and either kill them or deliver cancer-killing substances to them without harming normal cells.NCT00028665·Cleveland, Ohio TerminatedStudy of Tazemetostat in Lymphoid MalignanciesTazemetostat is an oral EZH2 inhibitor which has been FDA approved for adult patients with relapsed or refractory (R/R) follicular lymphoma (FL) whose tumors are positive for an…NCT05983965·Birmingham, Alabama RecruitingCD19-targeted CAR T Cells for Relapsed or Refractory (R/R) Large B-cell LymphomaThis is an open-label, single-arm study to treat the adult R/R Large B-cell Lymphoma subjects with Relmacabtagene autoleucel (relma-cel) in China.NCT06479356·Tianjin, Tianjin Municipality CompletedA Study of C-CAR039 Treatment in Subjects With r/r NHL SubjectsNon-Hodgkin's LymphomaThis is a single-center, open-label study to evaluate the safety and efficacy of C-CAR039 in relapsed and/or refractory B-NHL patients.NCT04655677·Beijing, Beijing/China

Related Searches

hodgkintrials non-hodgkintrials

Data from ClinicalTrials.govTerms

Active not recruitingMemory Enriched T Cells Following Stem Cell Transplant in Treating Patients With Recurrent B-Cell Non-Hodgkin LymphomaThis phase I trial studies the highest possible dose of memory enriched T cells that can be given following standard stem cell transplant before unmanageable side effects are seen…NCT02051257·Duarte, California

UnknownDecoding the Cognitive Trajectory of Hong Kong SuperAgers: a Longitudinal Follow-up StudyThis is a prospective follow-up study conducted at the Department of Psychiatry, The Chinese University of Hong Kong.NCT05728801·Hong Kong

RecruitingSafety and Efficacy of Anti-EBV Autologous TCR-T Cell Injection in Relapsed/Refractory EBV-Positive LymphomaThis study will test whether anti-EBV autologous TCR-T cell injection is safe and effective for patients with relapsed or refractory EBV-positive lymphoma who have HLA-A11:01.NCT07162012·Shanghai

RecruitingQuality Of Life On Elderly Patients With Low Grade Non-Hodgkin LymphomaAims of this study are to describe the variation of QoL (Quality of Life) during the clinical management of low-grade lymphoma in elderly subjects and to identify the most…NCT05524298·Alessandria, Alessandria and 20 others

CompletedPenostatin, Rituximab and Ontak and Allogeneic Natural Killer (NK) Cells for Refractory Lymphoid MalignanciesIn this study the investigators investigate a cell therapy strategy that could harness allogeneic effectors that can potentially mediate anti-lymphoma effect.NCT01181258·Minneapolis, Minnesota

CompletedRetrospective Analysis of Rituximab-containing Immunochemotherapy for Burkitt's or Burkitt-like Lymphoma in AdultsThis retrospective study is aimed at evaluating the safety and efficacy of rituximab-containing immunochemotherapy in adult patients with Burkitt's lymphoma (BL) or high-grade…NCT01809600·Incheon

Active not recruitingA Pilot "Window-3" Study of Acalabrutinib Plus Rituximab Followed by Brexucabtagene Autoleucel Therapy in Patients With Previously Untreated High-risk Mantle Cell LymphomaTo learn if giving acalabrutinib, rituximab, and brexucabtagene autoleucel to patients with previously untreated high-risk mantle cell lymphoma (MCL) can help to control the…NCT05495464·Houston, Texas

RecruitingPola-ZR2P in Previously Untreated DLBCLThe goal of this phase 2 trial is to test the safety and efficacy of Pola-ZR2P as induction therapy in patients with DLBCL.NCT06664411·Beijing, Beijing Municipality

RecruitingA Study of ARC-02 in B-cell NHLThis study is to assess safety, tolerability, pharmacokinetics (PK), pharmacodynamic (PD), and preliminary efficacy of ARC-02.NCT07691606·Los Angeles, California and 28 others

RecruitingEpcoritamab, Rituximab, Gemcitabine and Oxaliplatin (R-GemOx) as Salvage Therapy Before Autologous Stem Cell Transplant for the Treatment of Relapsed/Refractory Diffuse Large B-Cell LymphomaThis phase II trial tests how well epcoritamab in combination with rituximab, gemcitabine and oxaliplatin (R-GemOx) works as treatment given after the cancer has not responded to…NCT07365306·Duarte, California and 2 others

UnknownGender Bias in the Overuse Studies Conducting in Primary CareThe purpose of this study is to analyze whether the differences between men and women in the frequency of adverse events due to ignoring "Do not do" recommendations in primary…NCT05233852·Elche, Alicante

TerminatedFirst-in-Human (FIH) Trial of GEN3009 in Subjects With Relapsed or Refractory B-Cell Non-Hodgkin LymphomasThe drug that will be investigated in the study is an antibody, GEN3009. Since this is the first study of GEN3009 in humans, the main purpose is to evaluate safety.NCT04358458·Denver, Colorado and 16 others

CompletedClinical Study With Blinatumomab in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)The purpose of this study is to confirm whether the bispecific T-cell engager blinatumomab is effective and safe in the treatment of patients with relapsed/refractory diffuse…NCT01741792·Göttingen and 5 others

TerminatedAn Observational Study of MabThera/Rituxan (Rituximab) in Patients With Follicular LymphomaThis observational study will evaluate the safety and efficacy of MabThera/Rituxan (rituximab) in previously untreated patients with follicular lymphoma.NCT01609036·Athens and 3 others

RecruitingEpcoritamab and Rituximab for First-line Follicular LymphomaThe purpose of this study is to determine how effective and safe the combination of rituximab and epcoritamab is in treating patients with Follicular Lymphoma (FL) and who have…NCT05783609·Boston, Massachusetts and 5 others

Active not recruitingTreatment of Orelabrutinib+Hi-CVP Regimen for Previously Untreated MZLIn patients with previously untreated Marginal zone lymphoma (MZL), a treatment regimen of Orelabrutinib,Zuberitamab combined with…NCT07480863·Beijing

PreviousPage 290 of 330Next